1. Home
  2. BMR vs CMMB Comparison

BMR vs CMMB Comparison

Compare BMR & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.26

Market Cap

19.3M

Sector

Technology

ML Signal

HOLD

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$2.16

Market Cap

20.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMR
CMMB
Founded
2009
2004
Country
Israel
Israel
Employees
N/A
12
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.3M
20.5M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
BMR
CMMB
Price
$1.26
$2.16
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
★ $25.00
AVG Volume (30 Days)
28.1K
★ 106.6K
Earning Date
02-26-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 101.67
EPS
N/A
★ 0.04
Revenue
N/A
N/A
Revenue This Year
$1.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$55.00
Revenue Growth
N/A
N/A
52 Week Low
$1.06
$1.35
52 Week High
$3.24
$3.55

Technical Indicators

Market Signals
Indicator
BMR
CMMB
Relative Strength Index (RSI) 49.88 40.40
Support Level $1.22 $1.47
Resistance Level $1.41 $2.21
Average True Range (ATR) 0.06 0.21
MACD 0.01 -0.09
Stochastic Oscillator 47.37 8.97

Price Performance

Historical Comparison
BMR
CMMB

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd provides content-adaptive video compression solutions for human viewing and machine vision. The company is trusted by technology companies such as NVIDIA and Amazon Web Services, and serves media companies including Netflix, Paramount, and JioHotstar. Using Emmy-winning patented technology, its solutions help deliver media content with high quality while reducing storage and delivery costs. Its customers include over-the-top content distributors, video streaming platforms, and Hollywood studios that use its products to store, distribute, and monetize video and images across devices. The company operates in the United States, Israel, and the rest of the world, with the United States generating maximum revenue.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: